Gilles A. Salles, MD, PhD¹, Thomas E. Boyd, MD^2*, Franck Morschhauser, MD^3*, Clemens-Martin Wendtner, MD⁴, Michael Hallek, MD⁵, Barbara F. Eichhorst, MD⁵, Mark Kozloff, MD^6*, Guillaume Cartron, MD, PhD^7*, Yan Li^8*, James Hilger^8*, Mehrdad Mobasher, MD⁸ and Stephan Stilgenbauer, MD⁹

¹Hospices Civils de Lyon, University Claude Bernard, Pierre-Benite, France
²Yakima Valley Memorial Hospital, Yakima, WA
³Hematologie, Centre Hospitalier Universitaire, Université de Lille 2, Lille, France
⁴Klinikum Schwabing, Academic Teaching Hospital of University of Munich, Munich, Germany
⁵Department I of Internal Medicine, Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne, Cologne, Germany
⁶University of Chicago Medicine, Chicago, IL
⁷Department of Clinical Hematology, University Hospital of Montpellier, Montpellier, France
⁸Genentech, Inc., South San Francisco, CA
⁹Department of Internal Medicine III, Ulm University, Ulm, Germany

Shuo Ma, MD¹, Danielle M. Brander, MD², John F. Seymour, MBBS, PhD³, Thomas J. Kipps, MD, PhD⁴, Jacqueline C. Barrientos, MD⁵, Matthew S. Davids, MD⁶, Mary Ann Anderson, MBBS^7,8*, Michael Y. Choi, M.D.⁴, Constantine S. Tam, MBBS³, Tanita Mason-Bright^9*, Betty Prine^9*, Wijith Munasinghe, PhD^9*, Ming Zhu, PhD^9*, Su Young Kim, MD^9*, Rod A. Humerickhouse, MD, PhD⁹ and Andrew W. Roberts, MBBS, PhD^7,8

¹Northwestern University, Chicago
²Duke University Medical Center, Durham, NC
³Peter MacCallum Cancer Centre, Melbourne, Australia
⁴University of California, San Diego, La Jolla, CA
⁵Hofstra North Shore-LIJ School of Medicine, Hempstead, NY
⁶Dana-Farber Cancer Institute, Boston, MA
⁷Royal Melbourne Hospital, Melbourne, Australia
⁸Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
⁹AbbVie Inc., North Chicago, IL

John C. Byrd, MD¹, William Wierda, MD, PhD², Jeffrey Jones, MD, MPH¹, Susan O'Brien, MD³, Jennifer R. Brown, MD, PhD⁴, Anna Schuh, MD, PhD^5*, Peter Hillmen, MB, ChB, PhD⁶, Deborah M. Stephens, DO⁷, Paolo Ghia, MD, PhD⁸, Steve Devereux, MD⁹, Jorge M. Chaves, MD^10*, Jacqueline C. Barrientos, MD¹¹, Min Hui Wang, PhD^12*, Jane Huang, MD^12*, Todd Covey^13*, Tasheda Navarro^12*, Wayne Rothbaum^12*, Raquel Izumi, PhD¹³, Ahmed Hamdy, MBBCh¹³ and Richard R. Furman, MD¹⁴

¹Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
²University of Texas MD Anderson Cancer Center, Houston, TX
³University of California, Irvine, Orange, CA
⁴Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
⁵University of Oxford, Oxford, United Kingdom
⁶Dept. of Haematology/Oncology, St. James's University Hospital, Leeds, United Kingdom
⁷Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁸Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milano, Italy
⁹Kings College Hospital, NHS Foundation Trust, Denmark Hill, London, United Kingdom
¹⁰Northwest Medical Specialties, PLLC, Tacoma, WA
¹¹North Shore-LIJ, Lake Success, NY
¹²Acerta Pharma BV, Redwood City, CA
¹³Acerta Pharma, Redwood City, CA
¹⁴New York-Presbyterian/Weill Cornell Medical Center, New York, NY

Constantine Tam, MBBS, MD^1,2, Andrew P Grigg, MBBS MD³, Stephen Opat, MBBS^4,5, Matthew Ku, MBBS^3*, Michael Gilbertson, MBBS^4*, Mary Ann Anderson, MBBS^2,6,7, John F. Seymour, MBBS, PhD^2,8, David S. Ritchie, MD, PhD⁹, Carmen Dicorleto^4*, Belinda Dimovski^8*, Eric Hedrick^10*, Jianxin Yang^10*, Lai Wang, PhD^10*, Lusong Luo^10*, Ling Xue^10* and Andrew W. Roberts, MBBS, PhD^2,6,7

¹Peter MacCallum Cancer Centre, East Melbourne, Australia
²University of Melbourne, Melbourne, Australia
³Austin Health, Melbourne, Australia
⁴Monash Health, Melbourne, Australia
⁵Monash University, Melbourne, Australia
⁶Royal Melbourne Hospital, Melbourne, Australia
⁷Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
⁸Peter MacCallum Cancer Centre, Melbourne, Australia
⁹Royal Melbourne Hospital, Parkville, Australia
¹⁰Beigene (Beijing) Co. Ltd., Beijing, China

Stephan Stilgenbauer, MD¹, Jeffrey A. Jones, MD, MPH², Steven Coutre, MD³, Anthony R. Mato, MD, MSCE^4,5, Peter Hillmen, MB, ChB, PhD⁶, Constantine Tam, MBBS, MD⁷, Anders Osterborg, MD, PhD⁸, Tanya Siddiqi, MD⁹, Michael J. Thirman, MD¹⁰, Richard R. Furman, MD¹¹, Osman Ilhan^12*, Michael Keating, MBBS¹³, Timothy G. Call, MD¹⁴, Jennifer R. Brown, MD, PhD¹⁵, Yunfeng Li, PhD^16*, Karl Eckert, BA^16*, Betty Y. Chang, PhD¹⁶, Danelle F. James, MD, MAS^16*, Alvina D. Chu, MD^16*, Michael Hallek, MD¹⁷ and Susan O'Brien, MD¹⁸

¹Universitatsklinikum Ulm, Klinik fur Innere Medizin II, Ulm, Germany
²Division of Hematology, The Ohio State University, Columbus, OH
³Division of Hematology, Stanford Cancer Center, Stanford University School of Medicine, Stanford, CA
⁴Hackensack University Medical Center, Hackensack, NJ
⁵Department of Pathology and Laboratory Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁶The Leeds Teaching Hospitals, St. James Institute of Oncology, Leeds, United Kingdom
⁷Peter MacCallum Cancer Centre, East Melbourne, Australia
⁸Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden
⁹Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
¹⁰University of Chicago Medical Center, Chicago, IL
¹¹New York-Presbyterian/Weill Cornell Medical Center, New York, NY
¹²Ankara University Medical Faculty, Ankara, Turkey
¹³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴Division of Hematology, Mayo Clinic, Rochester, MN
¹⁵Dana-Farber Cancer Institute, Boston, MA
¹⁶Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA
¹⁷Department of Internal Medicine I, Center of Integrated Oncology (CIO), CECAD, University of Cologne, Cologne, Germany
¹⁸Department of Leukemia, The University of Texas MD Anderson Cancer Center,, Houston, TX

Wei Ding, MD, PhD¹, Haidong Dong, MD, PhD^2*, Timothy G. Call, MD¹, Tait D. Shanafelt, MD³, Sameer A. Parikh, MD¹, Jose F. Leis, MD, PhD⁴, Betsy R. Laplant, MS^5*, Rong He, MD^6*, Thomas E. Witzig, MD¹, Yi Lin, MD, PhD¹, Asher Chanan-Khan, MD⁷, Deborah A. Bowen, APRN, CNP^1*, Michael Conte, PA-C^1*, Thomas M. Habermann, MD¹, David Viswanatha, MD⁶, Ivana Micallef, MD¹, Neil E. Kay, MD¹ and Stephen Ansell, MD, PhD⁸

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Division of Urology, Mayo Clinic, Rochester, MN
³Department of Hematology, Mayo Clinic, Rochester, MN
⁴Department of Hematology, Mayo Clinic, Scottsdale, AZ
⁵Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN
⁶Division of Pathology, Mayo Clinic, Rochester, MN
⁷Division of Hematology, Mayo Clinic, Jacksonville, FL
⁸Mayo Clinic, Rochester, MN